ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ACUT Accustem Sciences Inc (QB)

0.38914
0.00 (0.00%)
Jun 18 2024 - Closed
Delayed by 15 minutes

Accustem Sciences (QB) Financial Summary

The current ACUT market cap is 4.42M. The company's latest EPS is USD -0.1808 and P/E is -2.16.

Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -670k-3.75M-2.05M
Net Income -670k-3.75M-2.05M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 1.35M940k134k
Total Liabilities 703k1.08M2.25M
Total Equity 650k-140k-2.11M

Cash Flow

Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating N/A -1.81M-1.62M
Investing N/A -11k N/A
Financing N/A 2.55M903k
Market Cap 4.42M
Price to Earnings Ratio -2.16
Price to Sales Ratio 0
Price to Cash Ratio 205.26
Price to Book Ratio -2.1
Dividend Yield -

Share Statistics

Shares Outstanding 11.35M
Average Volume (1 week) 1.11k
Average Volume (1 Month) 1.56k
52 Week Change -64.94%
52 Week High 1.95
52 Week Low 0.2707
Spread (Intraday) 0.15 (30.9%)

Company Info

Company Name Accustem Sciences Inc (QB)
Address 300 creek view road suite 209
newark, delaware 19711
Website https://www.accustem.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock